| |
Current Swiss Investments
ACRON HELVETIA VII
The investment property comprises the seven-story, fully leased "Portikon" office building located in Glattpark in Zurich-Opfikon. Construction of the building, which features an atrium, was completed in September 2009. The two main tenants, Baxter Healthcare S.A. and Nycomed International Management GmbH, operate in the pharmaceuticals and healthcare industries and together have leased around 90% of the available net leasable area until 2019. The property is the first project by the Swiss subsidiary of HOCHTIEF.
Portikon is currently the largest building in Switzerland designed and built according to the Swiss Minergie-P® standard, which is comparable to the German Passivhaus standard for energy efficiency. In addition to strict sustainability criteria, the Portikon property also follows the principles of electrobiological compatibility. Moreover, the property features one of the largest photovoltaic systems in Zurich, which produces nearly all of the electricity required for the building´s own technical systems. This comprehensive energy concept guarantees that ancillary costs will remain low for users while offering investors secure returns for the long term thanks to optimized life-cycle costs.
ACRON HELVETIA VII Immobilien AG
The investment company is structured as a private placement/qualified investment with a total investment amount of CHF 142 million. At a minimum investment of CHF 100,000, the forecast distribution will amount to 6.25 percent annually starting in 2010. At the beginning of 2014, the return is projected to increase to an annual rate of 6.50 percent. By 2024, the company will make distributions exclusively by way of tax-free par value reductions. Subsequently, there will be a combination of par value reductions and payment of a dividend.This investment opportunity is currently open for placement with qualified investors.
Name of Investment,
Private Placement |
ACRON HELVETIA VII Immobilien AG |
| Legal form |
Swiss stock corporation
CH-660.7.854.008-8 |
| Address/Registered office of the company |
ACRON HELVETIA VII Immobilien AG
c/o ACRON AG
Stockerstrasse 8
8002 Zurich
Switzerland |
| Year issued |
2009 |
| Year closed |
open |
| Number of shareholders |
open |
| The Property |
| Type of use |
Office property - Minergie P® |
| Address |
Thurgauerstrasse 130
8152 Glattpark
Zurich-Opfikon
Switzerland |
| Year constructed |
2009 |
| Site area |
6,622 m² (71,252 sq.ft.) |
| Net leasable area |
18,800 m² (193,680 sq.ft.) |
| Occupancy rate in % of total area |
100 |
| Rental income, in CHF |
7,834,239 |
| Parking spaces |
144 |
| The Tenants |
| Tenant I |
Baxter Healthcare S.A. |
| Lease term |
10 years until 31 July 2019 and 31 October 2019 respectively, two options to extend for 5 years, 100% indexing to Swiss consumer price index |
| Net leasable area |
45,94% |
| Tenant II |
Nycomed International Management GmbH |
| Lease term |
10 years until 31 December 2019, two options to extend for 5 years, 100% indexing to Swiss consumer price index
Onetime right of special termination to the
31 December 2014 with a compensation in the amount of a full year net rent. |
| Net leasable area |
44,71% |
| Tenant III |
Graf Z AG |
| Lease term |
10 years until 30 September 2019, two options to extend for 5 years, 100% indexing to Swiss consumer price index |
| Net leasable area |
5,35% |
| Tenant IV |
HOCHTIEF Facility Management Swiss AG |
| Lease term |
4 years until 14 July 2013, 100% indexing to Swiss consumer price index |
| Net leasable area |
0,85% |
| Tenant V |
HOCHTIEF Development Schweiz AG |
| Lease term |
Since June 1, 2010: 8 years until
31 May 2018, one option to extend for 5 years, 100% indexing to Swiss consumer price index |
| Net leasable area |
3,15% |
| Key Figures |
| Investment volume, in CHF |
142,000,000 |
| Share capital, in CHF |
55,000,000 |
| Borrowed funds, in CHF |
87,000,000 |
| Minimum investment, in CHF |
100,000 [qualified investor pursuant to the Swiss Federal Act on Collective Investment Schemes (KAG)] |
|
|